Eutilex Ltd.
Eutilex.Co.,Ltd. discovers and develops immunomodulatory antibody therapeutics to treat cancers and autoimmune diseases. It develops anti-tumor T cell therapy and antibody therapeutics. The company was founded in 2015 and is headquartered in Seoul, South Korea.
Headquarters: South Korea (KOR)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Professional Services
- Industry: Biotechnology Research
- HQ: Seoul
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.